Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 2.06TCr 308.38Cr 274.8Cr 254.42Cr 230.24Cr 433.78Cr 29TCr 438.92Cr 3.05TCr 1.2TCr 15TCr 1.16TCr 1.13TCr 49TCr P/E 2026 *
13.9x
P/E 2027 * 12x
Enterprise Value 1.73TCr 258.36Cr 230.22Cr 213.15Cr 192.89Cr 363.41Cr 24TCr 367.72Cr 2.56TCr 1TCr 13TCr 969.17Cr 948.99Cr 41TCr EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.52x
Free-Float
34.77%
Yield 2026 *
5.21%
Yield 2027 * 5.77%
1 day-0.93%
1 week-4.54%
Current month-0.66%
1 month-1.63%
3 months-3.93%
6 months+3.14%
Current year+2.61%
1 week 17.9
Extreme 17.9
19.38
1 month 17.32
Extreme 17.32
19.48
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.93%-4.54%-1.69%-21.83% 311.15Cr
-2.21%+7.45%-38.37%+10.25% 1.62TCr
+14.82%+0.81%+9.55%-19.05% 753.17Cr
-0.75%+4.31%-11.08%+0.62% 645.48Cr
-3.23%+3.31%-13.99%+3.77% 647.88Cr
-3.77%+2.98%-51.33%-34.78% 628.19Cr
-0.58%+1.50%+1.22%-3.86% 467.91Cr
+1.99%+4.88%-33.71%+3.80% 351.45Cr
-3.36%+1.10%-15.66%-11.35% 327.9Cr
-0.28%-2.07%-27.30%-36.71% 304.47Cr
Average +0.15%+3.06%-18.23%-10.91% 605.5Cr
Weighted average by Cap. +0.24%+3.98%-21.23%-6.43%

Financials

2026 *2027 *
Net sales 2.95TCr 442.41Cr 394.23Cr 365Cr 330.31Cr 622.31Cr 42TCr 629.69Cr 4.38TCr 1.72TCr 22TCr 1.66TCr 1.63TCr 70TCr 3.25TCr 487.06Cr 434.02Cr 401.83Cr 363.65Cr 685.12Cr 46TCr 693.24Cr 4.82TCr 1.89TCr 24TCr 1.83TCr 1.79TCr 77TCr
Net income 148.6Cr 22Cr 20Cr 18Cr 17Cr 31Cr 2.1TCr 32Cr 220.14Cr 86Cr 1.1TCr 83Cr 82Cr 3.52TCr 171.13Cr 26Cr 23Cr 21Cr 19Cr 36Cr 2.42TCr 36Cr 253.51Cr 99Cr 1.27TCr 96Cr 94Cr 4.05TCr
Net Debt -334.01Cr -50Cr -45Cr -41Cr -37Cr -70Cr -4.72TCr -71Cr -494.82Cr -194.16Cr -2.48TCr -187.66Cr -183.75Cr -7.91TCr -376.03Cr -56Cr -50Cr -46Cr -42Cr -79Cr -5.31TCr -80Cr -557.08Cr -218.59Cr -2.79TCr -211.27Cr -206.87Cr -8.9TCr
Projected Income Statement - Annual - DaShenLin Pharmaceutical Group Co., Ltd.
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
21/26/21 CN¥18.08 -0.93% 1,32,58,420
20/26/20 CN¥18.25 -4.30% 3,03,89,421
19/26/19 CN¥19.07 +2.47% 1,61,65,080
16/26/16 CN¥18.61 -0.69% 1,10,84,185
15/26/15 CN¥18.74 -1.32% 1,39,92,116
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.08CNY
Average target price
23.75CNY
Spread / Average Target
+31.36%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock